Shivang Mehta, MD
Transplant Hepatology · Fort Worth, TXNPI 1285918326
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,863 of the $5,913 with a category attached, or 65.3%. 18 manufacturers reported payments, led by Grifols Therapeutics LLC at 34.7% of the total. Reporting peaked in 2023 at $2,789 and has fallen 70.1% since, to $833 in 2025. That places this record below the midpoint for transplant hepatology clinicians in TX, where the typical reported total is $5,913.
Across 167 payments — averaging $35.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Grifols Therapeutics LLC$2K
- Gilead$2K
- AbbVie$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$180
- Intercept Pharmaceuticals, Inc.$180
- Grifols, S.A.$118
- plus $478 from 12 others
What the payments were for
- Consulting fees$2,05035%
- Food & beverage$3,86365%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Grifols Therapeutics LLC | 1 | $2,050 |
| Gilead | 73 | $1,727 |
| AbbVie | 52 | $1,180 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $180 |
| Intercept Pharmaceuticals, Inc. | 11 | $180 |
| Grifols, S.A. | 1 | $118 |
| Grifols Shared Services North America, Inc. | 1 | $95 |
| Shionogi Inc | 5 | $81 |
| Ipsen Biopharmaceuticals, Inc | 3 | $72 |
| Laborie Medical Technologies Corp. | 1 | $55 |
| Eisai Inc. | 2 | $54 |
| Medtronic | 1 | $20 |
| Novo Nordisk | 1 | $19 |
| Mallinckrodt Hospital Products Inc. | 1 | $18 |
| Boston Scientific | 1 | $18 |
| Perspectum Diagnostics Ltd | 1 | $17 |
| Mirum Pharmaceuticals, Inc. | 1 | $14 |
| Bayer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,913 in reported general payments places this provider in the 50th percentile of 28 transplant hepatology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XifaxanRifaximin | 62 | $195,343 |
| Ursodiol | 34 | $2,079 |
| Mycophenolate Mofetil | 28 | $1,765 |
| Tacrolimus | 28 | $1,625 |
| Lactulose | 53 | $1,571 |
| Spironolactone | 26 | $291 |
| Furosemide | 34 | $117 |
| Pantoprazole Sodium | 23 | $73 |
| Carvedilol | 19 | $69 |
| Prednisone | 13 | $60 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $180 | $195,34362 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 28 transplant hepatology providers in Texas.
Other transplant hepatology in Fort Worth
- Stevan GonzalezFort Worth$282K
- Themistoklis KourkoumpetisFort Worth$3K
- Omar HaqFort Worth$2K
- Abdullah MubarakTyler$362K
- Fernando MembrenoMcAllen$258K
- David VictorHouston$249K
- Prasun JalalHouston$247K
- Carmen LandaverdeSan Antonio$189K
- Hector NazarioDallas$161K
- Ashwini MehtaDallas$100K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.